Nomura Holdings (NMR) Stock
Key stats
- Market cap
- $27.79B
- Price / Earnings ratio
- 12.7x
- EPS (TTM)
- $0.78
- Volume
- Loading
- 52-week high
- $10.94
- 52-week low
- $6.88
- Dividend yield
- 0.00%
- Dividend amount (latest)
- $0.17
- EPS vs analyst estimate
- +23.5%Q2 FY26 · $0.21 vs $0.17
Source: third-party data provider, as of November 7, 2026
EPS estimate: analyst consensus
Compare with NMR
Recent news

NMR or TW: Which Is the Better Value Stock Right Now?
NMR or TW: Which Is the Better Value Stock Right Now?
NMR

Are Investors Undervaluing Nomura (NMR) Right Now?
Are Investors Undervaluing Nomura (NMR) Right Now?
NMR

NMR Q2 Earnings Call Highlights Wealth Growth and Cost Pressures
NMR Q2 Earnings Call Highlights Wealth Growth and Cost Pressures
NMR

Nomura to Report Q2 Earnings: What's in Store for the Stock?
Nomura to Report Q2 Earnings: What's in Store for the Stock?
NMR
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 50.80
- MACD 12/26/9
- -0.05
- EMA 9 of MACD
- -0.14
- MACD histogram
- 0.08
- SMA 50
- $9.82
- Price below SMA 50
- EMA 50
- $9.58
- Price below EMA 50
- SMA 200
- $9.01
- Price above SMA 200
- EMA 200
- $9.04
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2026Earnings
The market has no earnings per share expectations for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

NMR or TW: Which Is the Better Value Stock Right Now?
NMR or TW: Which Is the Better Value Stock Right Now?
NMR

Are Investors Undervaluing Nomura (NMR) Right Now?
Are Investors Undervaluing Nomura (NMR) Right Now?
NMR

NMR Q2 Earnings Call Highlights Wealth Growth and Cost Pressures
NMR Q2 Earnings Call Highlights Wealth Growth and Cost Pressures
NMR

Nomura to Report Q2 Earnings: What's in Store for the Stock?
Nomura to Report Q2 Earnings: What's in Store for the Stock?
NMR

NMR vs. TW: Which Stock Is the Better Value Option?
NMR vs. TW: Which Stock Is the Better Value Option?
NMR

Down 11.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Nomura (NMR)
Down 11.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Nomura (NMR)
NMR

Nomura (NMR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Nomura (NMR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
NMR

NMR or TW: Which Is the Better Value Stock Right Now?
NMR or TW: Which Is the Better Value Stock Right Now?
NMR

New Strong Buy Stocks for September 24th
New Strong Buy Stocks for September 24th
NMR

Best Income Stocks to Buy for September 24th
Best Income Stocks to Buy for September 24th
NMR
News tone: automated (AI) classification of the article's content, not a price prediction.
About Nomura Holdings
Nomura is a global financial services group with an integrated network spanning multiple countries and regions. By connecting markets East & West, we service the needs of individuals, institutions, corporates and governments through our three business divisions: Retail, Wholesale (Global Markets and Investment Banking) and Investment Management.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Kentaro Okuda | President, Group CEO, Representative Executive Officer & Director | 1963 |
| Mr. Christopher Paul Willcox | Executive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | 1968 |
| Hiroyuki Moriuchi | Executive Officer & CFO | 1976 |
| Mr. Sotaro Kato | Executive Officer & Chief Risk Officer | 1969 |
| Mr. Toshiyasu Iiyama | Chief of Staff, Exe. Off., Head of Well Growing Inst., Hd of China Committee & Deputy President | 1965 |
| Mr. Yutaka Nakajima | Representative Executive Officer, Deputy President & Director | 1965 |
| Mr. Takumi Kitamura | Executive Officer & Chief Transformation Officer | 1966 |
| Akio Hori | Senior MD & Chief Information Officer | — |
| Akihiro Koseki | MD, Head of Investor Relations & Co-Head of Investment Banking - Asia ex-Japan | — |
| Mr. Shinichi Mizuno | Senior MD, Joint Chief Compliance Officer & Audit Mission Director. | 1968 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 7, 2026
Technical indicators
- RSI 14
- 50.80
- MACD 12/26/9
- -0.05
- EMA 9 of MACD
- -0.14
- MACD histogram
- 0.08
- SMA 50
- $9.82
- Price below SMA 50
- EMA 50
- $9.58
- Price below EMA 50
- SMA 200
- $9.01
- Price above SMA 200
- EMA 200
- $9.04
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -7.5 | +4.3 | ||||||||||
| 2022 | +0.2 | +0.7 | -4.1 | -11.3 | +3.4 | -8.2 | +4.9 | -5.5 | -8.3 | -2.4 | +11.2 | +1.6 |
| 2023 | +7.2 | +2.0 | -7.5 | -7.3 | -1.1 | +7.6 | +7.7 | +0.5 | +1.0 | -3.5 | +1.5 | +8.7 |
| 2024 | +28.7 | +3.6 | +9.9 | -6.9 | +9.2 | -9.0 | +6.0 | -0.7 | -9.8 | -2.6 | +15.8 | -6.2 |
| 2025 | +11.5 | -0.2 | -5.5 | -9.0 | +10.5 | +6.6 | +1.2 | +7.6 | +1.5 | -0.3 | +6.2 | +9.8 |
| 2026 | +5.0 | +4.4 | -8.8 | -1.1 | +3.8 | +7.2 | +7.8 | +6.2 | -3.8 | -3.7 | +2.3 |
Corporate actions
Upcoming
No upcoming corporate actions for NMR




